Pulling SEC filings + quote and writing the call…
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.06B | $1.07B | $1.12B | $1.04B | $1.63B | $1.38B | $1.28B | $1.41B | $1.50B | $1.54B |
| Revenue growth | — | 1.6% | 3.9% | -6.9% | 56.9% | -15.2% | -7.2% | 9.9% | 6.0% | 2.8% |
| Operating income | $303M | $275M | — | — | — | — | — | — | — | — |
| Operating margin | 28.6% | 25.6% | — | — | — | — | — | — | — | — |
| Net income | $141M | $148M | $287M | -$88.2M | -$139M | $175M | -$15.8M | -$294M | -$370M | -$286M |
| Net margin | 13.4% | 13.7% | 25.7% | -8.5% | -8.5% | 12.6% | -1.2% | -20.8% | -24.8% | -18.6% |
| EPS (diluted) | $0.60 | $0.62 | $1.21 | -$0.37 | -$0.59 | $0.73 | -$0.07 | -$1.23 | -$1.55 | -$1.19 |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $424M | $419M | $393M | $266M | $159M | -$63.3M | -$40.4M | $10.5M | $112M | -$19.6M |
| Share buybacks | $452K | $341K | $411K | $299K | $171K | $383K | $171K | $393K | $904K | $1.15M |
| Dividends paid | $370M | $371M | $371M | $200M | $42.8M | $9.54M | $9.57M | $9.60M | $9.63M | $9.66M |
| Fiscal year | FY2016 | FY2017 | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $31.7M | $31.2M | $55.0M | $37.4M | $74.4M | $635M | $658M | $246M | $145M | $105M |
| Total assets | $7.23B | $7.29B | $7.16B | $6.65B | $6.48B | $6.62B | $6.00B | $5.45B | $5.14B | $4.36B |
| Total liabilities | $4.03B | $4.02B | $3.98B | $3.78B | $3.86B | $3.96B | $3.36B | $3.11B | $3.18B | $2.70B |
| Long-term debt | — | — | $3.68B | — | — | — | — | — | $3.05B | $2.44B |
| Shareholders' equity | $3.20B | $3.10B | $3.02B | $2.74B | $2.50B | $2.66B | $2.64B | $2.34B | $1.96B | $1.67B |
| Retained earnings | $1.62B | $1.77B | $2.14B | $2.05B | $1.91B | $2.09B | $2.07B | $1.78B | $1.41B | $1.12B |
| Shares (wtd avg diluted) | 237M | 237M | 238M | 238M | 238M | 238M | 238M | 239M | 240M | 240M |
Every figure is extracted from DIVERSIFIED HEALTHCARE TRUST’s annual reports as filed with the SEC (XBRL company facts) — no third-party estimates. Fiscal years are labeled by period end; filers occasionally re-tag concepts, so a sparse cell means the company didn’t report that concept for that year. Free cash flow = operating cash flow − capital expenditures.
Research and education only — not financial advice. TENKis not a registered investment adviser or broker-dealer and gives no personalized advice. Every call is impersonal — identical for all users, generated on a schedule from SEC filings plus a delayed/third-party price feed — may be wrong or out of date, and is not a recommendation to buy or sell any security. The operator and an affiliated trading operation may hold or trade the securities TENK rates; see Disclosures. Past performance does not guarantee future results. Do your own research.